Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07141537 · ClinicalTrials.gov registry record
Caloric Balance Markers Study
A clinical trial of Metabolism, sponsored by Institute for Systems Biology.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT07141537 is a study of Metabolism that is actively recruiting participants, run by Institute for Systems Biology. The registered enrollment target is 400 participants, below the 13,245-participant average among 19 other Metabolism trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07141537, a study of Metabolism, is actively recruiting participants, sponsored by Institute for Systems Biology.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of CaBooM is to identify and characterize biomarkers of caloric balance-the relationship between energy intake (calories consumed) and energy expenditure (calories burned).
Conditions Studied
Study Locations (1)
Washington
- Institute for Systems Biology - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2025-08-27 |
| Est. Completion | 2033-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07141537
The ClinicalTrials.gov registry entry for NCT07141537 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 13,245-participant average among 19 other Metabolism trials with a reported enrollment target (97% lower). The listed sponsor is Institute for Systems Biology, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Metabolism appearing as the primary indexed condition, and to 0 interventions.
NCT07141537 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT07141537 about?
NCT07141537 is a clinical study titled "Caloric Balance Markers Study". The purpose of CaBooM is to identify and characterize biomarkers of caloric balance-the relationship between energy intake (calories consumed) and energy expenditure (calories burned).
What is the current status of trial NCT07141537?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2025-08-27. Estimated completion is 2033-08-31.
What conditions does trial NCT07141537 study?
This clinical trial studies the following conditions: Metabolism.
Who is sponsoring clinical trial NCT07141537?
This trial is sponsored by Institute for Systems Biology, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07141537 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women
RECRUITING · NA
-
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
RECRUITING · Phase 2
-
Studying Phenotypic Risks for Obesity and Underlying Traits in Young Infants
RECRUITING
-
Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells
RECRUITING · NA
-
Personalized Responses to Dietary Composition Trial 3
RECRUITING · NA
-
Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.